Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System

Volume 5, Issue 4 Pub Date : 2020-07-30 DOI:10.46243/jst.2020.v5.i4.pp261-267

S. Chaudhari, Sneha U. Gaikwad

{"title":"Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System","authors":"S. Chaudhari, Sneha U. Gaikwad","doi":"10.46243/jst.2020.v5.i4.pp261-267","DOIUrl":null,"url":null,"abstract":"Vesicular drug delivery system has various advantages thereby improving therapeutic efficacy and by\nsustaining and controlling action of drugs. Liposomes, sphingosomes, ethosomes, cubosomes, pharmacasomes,\nniosomes, transferosomes are the newly developed vesicular drug delivery system. This review article mainly deals\nwith the sphingosomal drug delivery system. Sphingosomes are vesicular drug delivery systems in which an aqueous\nvolume is enclosed with sphingolipid bilayer membranes. Sphingosomes has an enhanced area of interest because of\ntheir applicability in improving the in vivo delivery of various chemotherapeutic agents, biological macromolecules\nand diagnostics. Sphingosome has major advantages over other vesicular drug delivery systems like high stability,\nmore in vivo circulation time, high tumor loading efficacy in case of cancer therapy as compared to liposomes,\nniosomes etc. Sphingosomes are clinically used vesicular delivery system for chemotherapeutic agent, biological\nmacromolecule and diagnostics. This review concluded that sphingosome represents a promising vesicular drug\ndelivery system for a range of possible therapeutic applications.","PeriodicalId":23534,"journal":{"name":"Volume 5, Issue 4","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Volume 5, Issue 4","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46243/jst.2020.v5.i4.pp261-267","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

Abstract

Vesicular drug delivery system has various advantages thereby improving therapeutic efficacy and by sustaining and controlling action of drugs. Liposomes, sphingosomes, ethosomes, cubosomes, pharmacasomes, niosomes, transferosomes are the newly developed vesicular drug delivery system. This review article mainly deals with the sphingosomal drug delivery system. Sphingosomes are vesicular drug delivery systems in which an aqueous volume is enclosed with sphingolipid bilayer membranes. Sphingosomes has an enhanced area of interest because of their applicability in improving the in vivo delivery of various chemotherapeutic agents, biological macromolecules and diagnostics. Sphingosome has major advantages over other vesicular drug delivery systems like high stability, more in vivo circulation time, high tumor loading efficacy in case of cancer therapy as compared to liposomes, niosomes etc. Sphingosomes are clinically used vesicular delivery system for chemotherapeutic agent, biological macromolecule and diagnostics. This review concluded that sphingosome represents a promising vesicular drug delivery system for a range of possible therapeutic applications.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

鞘体:一种新型脂质囊状给药系统

囊泡给药系统具有多种优点，通过维持和控制药物的作用来提高治疗效果。脂质体、鞘体、脂质体、立方体体、药质体、乳质体、转移体是近年来发展起来的囊状给药系统。本文主要对鞘体给药系统进行综述。鞘小体是囊状药物传递系统，其水体积被鞘脂双层膜包裹。鞘小体具有增强的兴趣领域，因为它们在改善各种化疗药物，生物大分子和诊断的体内递送方面的适用性。与其他囊泡给药系统相比，鞘小体具有稳定性高、体内循环时间长、肿瘤负载效率高等优点。鞘小体是临床上用于化疗药物、生物大分子和诊断的囊泡输送系统。本综述认为鞘小体是一种具有广泛应用前景的囊泡给药系统。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Volume 5, Issue 4

自引率

0.00%

发文量